The Men’s Guide To Staying Young… – ThyBlackMan
February 24th, 2011
Denosumab vs zoledronate to stop cancer-related fractures: tough call Curetoday.com (press release) As reported last year, the newer drug was superior to zoledronic acid at preventing SREs in two phase III trials in patients with breast or prostate cancer. (See Reuters Health articles of Jun 7 and Nov 9, 2010.) Based on those trials and the current ... |
Source:
prostate cancer articles - Google News
Entry Filed under: CANCER,Prostate Cancer,Prostate Health
Leave a Comment
You must be logged in to post a comment.
Subscribe to the comments via RSS Feed